Since high PCNA+ TAM counts are associated with hormone receptor negative (HR-neg) breast cancers and since these HR-neg cancers tend to have worse outcomes, we also examined the Tc/Class II signature and PCNA+ TAMs in HR-neg cases only. This evidence concerns the gene NR4A1 and breast carcinoma.